Mani Foroohar

Roy Buchanan

Chen Yang

Ellie Merle

Jonathan Miller

Jiale Song

Max Star

Umer Raffat

Eliana Merle

Rajan Sharma

Roger Song

- **CureVac N.V. will hold an Extraordinary General Meeting (EGM) on November 25, 2025**, to vote on the post-offer reorganization related to BioNTech SE's exchange offer for its ordinary shares.  **[1809122_0001104659-25-102252_tm2529451d1_ex99-1.htm:0]** 
- **BioNTech SE's exchange offer, which began on October 21, 2025, is set to expire on December 3, 2025, at 9:00 a.m. New York City time**.  **[1809122_0001104659-25-102252_tm2529451d1_ex99-1.htm:2]** 
- The proposed post-offer reorganization includes a **Legal Downstream Merger** of CureVac N.V. into CureVac Merger B.V. ("New Topco"), followed by the sale of CureVac SE shares to BioNTech SE and the cancellation of New Topco A shares.  **[1809122_0001104659-25-102252_tm2529451d1_ex99-1.htm:0]** **[1809122_0001104659-25-102252_tm2529451d1_ex99-3.htm:1]** **[1809122_0001104659-25-102252_tm2529451d1_ex99-1.htm:4]** 
- The reorganization is conditional on BioNTech SE acquiring at least **80%** (or **75%** if amended) of CureVac's outstanding share capital.  **[1809122_0001104659-25-102252_tm2529451d1_ex99-1.htm:5]** 
- Shareholders who do not tender their shares in the offer may incur **Dutch dividend withholding tax** on the cancellation consideration, potentially resulting in a lower after-tax return.  **[1809122_0001104659-25-102252_tm2529451d1_ex99-1.htm:5]** **[1809122_0001104659-25-102252_tm2529451d1_ex99-1.htm:6]**

CureVac N.V. Schedules EGM for BioNTech SE Exchange Offer and Post-Offer Reorganization

CureVac (CVAC)